The chemical analyses results herein showed that the EO of A. graveolens specimen contains a major component, particularly high amounts of alpha-phellandrene (59%) indicating that this widely cultivated plant may account as a novel-alternative industrial source for this molecule. The insecticide properties of the EOs studied – and their most abundant compounds Pevonedistat – were evaluated against the Culex pipiens L larvae of 3rd and early 4th instars. Results indicated that many of them display noteworthy toxicity, with the EO of A. graveolens being the most active, displaying an LC50 value of 52.74 mg L-1. The EOs of E. tenuifolia ssp. sibthorpiana and C. aromaticum were also highly active exhibiting
LC50 values near 60 mg L-1. Among the tested oils, the EO of CCI-779 nmr A. graveolens exhibits noteworthy potentials for use either as bioremediation cultivar in mosquito-thriving areas and/or the development of novel biocides for the control of mosquitoes. (C) 2012 Elsevier B.V. All rights reserved.”
“Objective. To assess opinions, knowledge, and informational resources of obstetrician-gynaecologists regarding the safety of medication use during pregnancy.
Methods. A questionnaire was mailed to 770 members of the American College of Obstetricians and Gynecologists who participate in the Collaborative Ambulatory Research Network.
Results. The response rate was 58%. Of these, 305 respondents provide
both routine gynecologic and obstetric care and are the focus of the study. There click here was wide variation in obstetrician-gynaecologists’ assessments of the safety for the foetus of medications ranging from aspirin to valproic acid. The Physicians’ Desk Reference was most frequently (75%) cited as a source of information about medication safety. Forty-two percent of obstetrician-gynaecologists selected lack of sufficient information on medications as the greatest barrier
to counselling pregnant women about their use, while only 4% selected lack of access to information as the greatest barrier. Most (79%) obstetrician-gynaecologists indicated they would be willing to participate in pregnancy exposure registries, but far fewer (24%) reported having done so.
Conclusion. These results emphasise the need for safety information about the effects of medication use during pregnancy and suggest that pregnancy exposure registries are underutilised.”
“Rhinosinusitis is one of the most common conditions for which patients seek medical care. Subtypes of rhinosinusitis include acute, subacute, recurrent acute, and chronic. Acute rhinosinusitis is further specified as bacterial or viral. Most cases of acute rhinosinusitis are caused by viral infections associated with the common cold. Symptomatic treatment with analgesics, decongestants, and saline nasal irrigation is appropriate in patients who present with nonsevere symptoms (e.g.